EPISODE · Mar 18, 2020 · 1H 4M
Dr. Michael Mina of the Harvard T.H. Chan School of Public Health
from Talks at GS · host Goldman Sachs
In this episode, Dr. Michael Mina of the Harvard T.H. Chan School of Public Health discusses the evolving understanding of COVID-19 biology and epidemiology and approaches to “flatten the curve” in the context of diagnostics, potential therapeutics and vaccines. This conversation was recorded as a phone call between Dr. Mina and Salveen Richter and Terence Flynn of Goldman Sachs Research on March 17, 2020. This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity. Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
In this episode, Dr. Michael Mina of the Harvard T.H. Chan School of Public Health discusses the evolving understanding of COVID-19 biology and epidemiology and approaches to “flatten the curve” in the context of diagnostics, potential therapeutics and vaccines. This conversation was recorded as a phone call between Dr. Mina and Salveen Richter and Terence Flynn of Goldman Sachs Research on March 17, 2020. This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity. Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Dr. Michael Mina of the Harvard T.H. Chan School of Public Health
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.